Ionis Pharmaceuticals, Inc. announced that topline results from the Phase 2b SOLANO study in patients with hypercholesterolemia demonstrated that 60mg of ION449 (AZD8233) administered...
The U.S. Food and Drug Administration (FDA) has granted QT Imaging, Inc. 510(K) clearance to calculate the fibroglandular volume (FGV) of the breast and...
Brooks Rehabilitation first participant in the national stroke recovery trial, EMAGINE, has just completed study participation. The randomized, double-blind study tests whether a non-invasive,...
Proponent, the largest independent aerospace distributor in the world, is pleased to announce the expansion of our partnership with AmSafe Bridport, a world-leading manufacturer...
